Circulating substances and energy metabolism in septic shock *

This publication has 23 references indexed in Scilit:

• Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase*
  Critical Care Medicine, 2003
• An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shock
  Critical Care Medicine, 1999
• Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.
  The Journal of Experimental Medicine, 1996
• Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase
  FEBS Letters, 1995
• Nitric Oxide Potently and Reversibly Deenergizes Mitochondria at Low Oxygen Tension
  Biochemical and Biophysical Research Communications, 1994
• Skeletal muscle partial pressure of oxygen in patients with sepsis
  Critical Care Medicine, 1994
• Nitric oxide mediates lipopolysaccharide-induced alteration of mitochondrial function in cultured hepatocytes and isolated perfused liver
  Hepatology, 1993
• Concurrent quantification of tissue metabolism and blood flow via ²h/³¹P NMR in Viva iii. alterations of muscle blood flow and metabolism during sepsis
  Magnetic Resonance in Medicine, 1992
• Dependence of oxygen consumption on cardiac output in sepsis
  Critical Care Medicine, 1987
• A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.
  Journal of Clinical Investigation, 1985